Aristotle University Of Thessaloniki (AUTH)
Συγκριτική μελέτη μεταξύ test Παπανικολάου και HPV DNA test ως μεθόδων πληθυσμιακού ελέγχου για την πρόληψη του καρκίνου του τραχήλου της μήτρας
Abstract
dc:descriptionBackground: Cervical cancer ranks fourth worldwide in terms of incidence. However, it is a disease that can be cured if timely made, through diagnostics. The last 60 years, as a method of preventing the so-called Papanicolaou smear test (Pap test) was widely used whose contribution in the treatment of disease of cervical cancer, it is considered large, as deaths from this cancer reduced the list to 74%. Over time however, as there were cases where the findings, the Pap test was unclear or even false positive or negative, the constraints have been identified, in terms of sensitivity. The discovery of Harald zur Hausen that human papillomavirus is associated with cervical cancer, led to interest scholars in new research paths,that led to the decoding of the virus. Based on the new findings developed new diagnostic and protection methods. Thus, developed and made available as a precaution the vaccine virus and the HPV DNA test which is considered to have higher sensitivity both traditional Pap test and the most modern liquid based Pap test. Over time, as the HPV DNA test gaining ever more ground, due to better efficiency and accuracy in diagnosis, several scholars have sought to evaluate and compare the two prevention methods (Pap test and HPV DNA test ). Thus, in the literature identified from studies and meta-analyses, without further enhanced some of the methods. However the studies and analyses carried out, updated the positive aspects of the methods and identified their weaknesses by creating the conditions for improving them, while many of the researchers concluded that the combination of both methods may prove more useful in field of prevention. StudyThe objective of the present research was to evaluate the performance of the liquid-based cytology test (LBC)as a method of primary pre-symptomatic cervical cancer screening for the Greek population, comparing with HPV DNA test the high-risk types of human papillomavirus (HR-HPV) and also the two virus types that are responsible for the most of cervical cancer cases (HPV16/HPV18). Subjects - MethodsDuring the research 4,009 women 25 to 55 years old were checked. They participated in a systematic examination for cervical screening in nine different University Gynecological Departments in Greece. At their first visit, cervical smears were examined via LBC and HPV DNA detection, using the Roche Cobas 4800 system. Women, who were found positive either for LBC test or HPV test, were referred to colposcopy. Women who were negative for both tests will be retested after three years.΅ResultsFinal measurements were available for 3,993 women. The overall prevalence of HR-HPV was 12.7%, of HPV16 2.7% and of HPV18 1.4%. From the cases that referred to colposcopy, cervical intraepithelial neoplasia grade 2 or worse (CIN2+) was detected in 41 women (1.07%). For the detection of intraepithelial lesions of moderate degree or worse (CIN2+), the Pap test and HPV DNA test presented sensitivity 53,7% and 100% respectively, without differences between the age-related groups. The performance of cytology Papanikolaou and HPV DNA test showed specificity 96,8% and 90,3% respectively, which was increased for older women (>30y) compared to younger ones (25-29y). Genotype HPV16/18 had a similar precision with cytology regarding the detection of CIN2+ (sensitivity: 58,5%, specificity 97,5%), as well as for referral colposcopy (sensitivity: 58,5% vs opposite 53,7% for cytology). ConclusionThe results shows that DNA test, compared to cytology, has much better sensitivity for the detection of CIN2 with slightly lower specificity. The control HPV with individual genotype HPV16 /HPV18 could represent a more precise methodology for the primary cervical cancer screening compared to the cytology based screening particularly in older women.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2020
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Katsamagkas, Taxiarchis
- Κατσαμάγκας, Ταξιάρχης
Subjects
dc:subject × 13- Καρκίνος τραχήλου της μήτρας
- Τεστ Παπανικολάου
- Κυτταρολογία υγρής φάσης
- Προληπτικός έλεγχος για τον καρκίνο του τραχήλου της μήτρας
- Cervical cancer
- Pap test
- Liquid based cytology
- HPV DNA test
- Cervical cancer screening
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/47525